이니스트팜

비상장계속사업자

INISTPHARM CO.,LTD

신현경

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

이니스트팜

Business Reg. No. 1188115730 · CEO 신현경

I.Investment Overview

Target이니스트팜 (1188115730)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명이니스트팜
영문명INISTPHARM CO.,LTD
대표자신현경
사업자등록번호1188115730
법인등록번호1101111348112
설립일1996.12.03
종업원수5명

V.Workforce

5

Current headcount · 2026.06 as of

VI.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW146.82019155.92020127.920211162024120.22025
영업이익100M KRW-1520191.12020-10.820215.920244.62025
순이익100M KRW36201920.12020-19.420211.320243.32025
Item20252024202120202019
자산총계114.7억원113.8억원117.3억원145억원197.1억원
부채총계65.6억원68.1억원67.3억원75.6억원142.3억원
자본총계49.1억원45.7억원50억원69.4억원54.8억원
매출액120.2억원116억원127.9억원155.9억원146.8억원
영업이익4.6억원5.9억원-10.8억원1.1억원-15억원
순이익3.3억원1.3억원-19.4억원20.1억원36억원

VII.Financial Ratios

FY2025 basis

3.83%

영업이익률

2.78%

순이익률

2.91%

ROA

6.81%

ROE

133.73%

부채비율

42.78%

자기자본비율

VIII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

이니스트팜 투심보고서 | Alpha Lenz